Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark E Jones

Showing results (51-60 of 65) with videos related to

Pageof 7
Sort By:
Angewandte Chemie (International Ed. in English)|May 28, 2008
Catalytic hydrogen-chlorine exchange between chlorinated hydrocarbons under oxygen-free conditionsAlwies W A M van der Heijden, Simon G Podkolzin, Mark E Jones, et al.
Antimicrobial Agents and Chemotherapy|May 23, 2003
Susceptibilities to levofloxacin in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis clinical isolates from children: results from 2000-2001 and 2001-2002 TRUST studies in the United StatesJames A Karlowsky, Clyde Thornsberry, Ian A Critchley, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 26, 2002
Regional trends in antimicrobial resistance among clinical isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States: results from the TRUST Surveillance Program, 1999-2000Clyde Thornsberry, Daniel F Sahm, Laurie J Kelly, et al.
International Journal of Antimicrobial Agents|January 30, 2002
Susceptibility to fluoroquinolones among commonly isolated Gram-negative bacilli in 2000: TRUST and TSN data for the United States. Tracking Resistance in the United States Today. The Surveillance NetworkJames A Karlowsky, Laurie J Kelly, Clyde Thornsberry, et al.
International Journal of Antimicrobial Agents|September 26, 2002
Phenotypic and genotypic analysis of levofloxacin-resistant clinical isolates of Streptococcus pneumoniae collected in 13 countries during 1999-2000Ian A Critchley, Renée S Blosser-Middleton, Mark E Jones, et al.
Antimicrobial Agents and Chemotherapy|May 23, 2002
In vitro activities of novel nonfluorinated quinolones PGE 9262932 and PGE 9509924 against clinical isolates of Staphylococcus aureus and Streptococcus pneumoniae with defined mutations in DNA gyrase and topoisomerase IVMark E Jones, Ian A Critchley, James A Karlowsky, et al.
Journal of Clinical Microbiology|March 7, 2002
Antimicrobial surveillance of Haemophilus influenzae in the United States during 2000-2001 leads to detection of clonal dissemination of a beta-lactamase-negative and ampicillin-resistant strainJames A Karlowsky, Ian A Critchley, Renée S Blosser-Middleton, et al.
Chemotherapy|December 12, 2002
The activity of levofloxacin and comparator agents against clinical isolates of Streptococcus pneumoniae collected worldwide during 1999 and 2000Mark E Jones, Renee S Blosser-Middleton, Ian A Critchley, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 22, 2002
Staphylococcus aureus small colony variants: rate of selection and MIC values compared to wild-type strains, using ciprofloxacin, ofloxacin, levofloxacin, sparfloxacin and moxifloxacinFranz-Josef Schmitz, Christof von Eiff, Mechthild Gondolf, et al.
Antimicrobial Agents and Chemotherapy|October 31, 2018
Outcomes by MIC Values for Patients Treated with Isavuconazole or Voriconazole for Invasive Aspergillosis in the Phase 3 SECURE and VITAL TrialsDavid R Andes, Mahmoud A Ghannoum, Pranab K Mukherjee, et al.
Pageof 7

Showing results (51-60 of 65) with videos related to

Sort By:
Pageof 7
Angewandte Chemie (International Ed. in English)|May 28, 2008
Catalytic hydrogen-chlorine exchange between chlorinated hydrocarbons under oxygen-free conditionsAlwies W A M van der Heijden, Simon G Podkolzin, Mark E Jones, et al.
Antimicrobial Agents and Chemotherapy|May 23, 2003
Susceptibilities to levofloxacin in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis clinical isolates from children: results from 2000-2001 and 2001-2002 TRUST studies in the United StatesJames A Karlowsky, Clyde Thornsberry, Ian A Critchley, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 26, 2002
Regional trends in antimicrobial resistance among clinical isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States: results from the TRUST Surveillance Program, 1999-2000Clyde Thornsberry, Daniel F Sahm, Laurie J Kelly, et al.
International Journal of Antimicrobial Agents|January 30, 2002
Susceptibility to fluoroquinolones among commonly isolated Gram-negative bacilli in 2000: TRUST and TSN data for the United States. Tracking Resistance in the United States Today. The Surveillance NetworkJames A Karlowsky, Laurie J Kelly, Clyde Thornsberry, et al.
International Journal of Antimicrobial Agents|September 26, 2002
Phenotypic and genotypic analysis of levofloxacin-resistant clinical isolates of Streptococcus pneumoniae collected in 13 countries during 1999-2000Ian A Critchley, Renée S Blosser-Middleton, Mark E Jones, et al.
Antimicrobial Agents and Chemotherapy|May 23, 2002
In vitro activities of novel nonfluorinated quinolones PGE 9262932 and PGE 9509924 against clinical isolates of Staphylococcus aureus and Streptococcus pneumoniae with defined mutations in DNA gyrase and topoisomerase IVMark E Jones, Ian A Critchley, James A Karlowsky, et al.
Journal of Clinical Microbiology|March 7, 2002
Antimicrobial surveillance of Haemophilus influenzae in the United States during 2000-2001 leads to detection of clonal dissemination of a beta-lactamase-negative and ampicillin-resistant strainJames A Karlowsky, Ian A Critchley, Renée S Blosser-Middleton, et al.
Chemotherapy|December 12, 2002
The activity of levofloxacin and comparator agents against clinical isolates of Streptococcus pneumoniae collected worldwide during 1999 and 2000Mark E Jones, Renee S Blosser-Middleton, Ian A Critchley, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 22, 2002
Staphylococcus aureus small colony variants: rate of selection and MIC values compared to wild-type strains, using ciprofloxacin, ofloxacin, levofloxacin, sparfloxacin and moxifloxacinFranz-Josef Schmitz, Christof von Eiff, Mechthild Gondolf, et al.
Antimicrobial Agents and Chemotherapy|October 31, 2018
Outcomes by MIC Values for Patients Treated with Isavuconazole or Voriconazole for Invasive Aspergillosis in the Phase 3 SECURE and VITAL TrialsDavid R Andes, Mahmoud A Ghannoum, Pranab K Mukherjee, et al.
Pageof 7